ANVS
#4091
Annovis Bio, Inc. Common Stock
1.7 0 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.30%
Variación mensual
-3.95%
Variación en los últimos 6 meses
-32.00%
Cambio anual
-26.41%
Cierres anteriores
1.7 4
Open
1.6 9
Mínimo
1.6 8
Máximo
1.7 0
Volumen
53
Financials
- Market Capitalization 72.43 M
- Employee 7
- Founded 2008
- CEO Maria-luisa Maccecchini
- Website www.annovisbio.com
- Headquarter Delaware, United States
- FIGI BBG00PN9XD40
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4070 |  CING Cingulate Inc. - Common Stock | 5.11 USD | -1.16% | -12.80% | +4.93% | -17.05% | 74.31 M USD | ||
| 4074 |  NRXS Neuraxis, Inc. Common Stock | 5.76 USD | -3.84% | -5.73% | -10.42% | +6.08% | 72.33 M USD | ||
| 4098 |  MNOV MediciNova, Inc. - Common Stock | 1.44 USD | 0.00% | -7.69% | +9.09% | +10.77% | 70.88 M USD | ||
| 4105 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.20 USD | -1.64% | -2.44% | +1.69% | -41.18% | 69.88 M USD |